Literature DB >> 29856551

Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Cathy Davies1, Andrea Cipriani2, John P A Ioannidis3,4,5,6,7, Joaquim Radua1,8,9, Daniel Stahl10, Umberto Provenzani1,11, Philip McGuire12,13, Paolo Fusar-Poli1,11,13,14.   

Abstract

Preventing psychosis in patients at clinical high risk may be a promising avenue for pre-emptively ameliorating outcomes of the most severe psychiatric disorder. However, information on how each preventive intervention fares against other currently available treatment options remains unavailable. The aim of the current study was to quantify the consistency and magnitude of effects of specific preventive interventions for psychosis, comparing different treatments in a network meta-analysis. PsycINFO, Web of Science, Cochrane Central Register of Controlled Trials, and unpublished/grey literature were searched up to July 18, 2017, to identify randomized controlled trials conducted in individuals at clinical high risk for psychosis, comparing different types of intervention and reporting transition to psychosis. Two reviewers independently extracted data. Data were synthesized using network meta-analyses. The primary outcome was transition to psychosis at different time points and the secondary outcome was treatment acceptability (dropout due to any cause). Effect sizes were reported as odds ratios and 95% confidence intervals (CIs). Sixteen studies (2,035 patients, 57% male, mean age 20.1 years) reported on risk of transition. The treatments tested were needs-based interventions (NBI); omega-3 + NBI; ziprasidone + NBI; olanzapine + NBI; aripiprazole + NBI; integrated psychological interventions; family therapy + NBI; D-serine + NBI; cognitive behavioural therapy, French & Morrison protocol (CBT-F) + NBI; CBT-F + risperidone + NBI; and cognitive behavioural therapy, van der Gaag protocol (CBT-V) + CBT-F + NBI. The network meta-analysis showed no evidence of significantly superior efficacy of any one intervention over the others at 6 and 12 months (insufficient data were available after 12 months). Similarly, there was no evidence for intervention differences in acceptability at either time point. Tests for inconsistency were non-significant and sensitivity analyses controlling for different clustering of interventions and biases did not materially affect the interpretation of the results. In summary, this study indicates that, to date, there is no evidence that any specific intervention is particularly effective over the others in preventing transition to psychosis. Further experimental research is needed.
© 2018 World Psychiatric Association.

Entities:  

Keywords:  Psychosis; antipsychotics; cognitive behavioural therapy; family therapy; guidelines; integrated psychological interventions; needs-based interventions; network meta-analysis; omega-3; prevention; risk

Year:  2018        PMID: 29856551      PMCID: PMC5980552          DOI: 10.1002/wps.20526

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  95 in total

Review 1.  GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.

Authors:  Gordon Guyatt; Andrew D Oxman; Shahnaz Sultan; Jan Brozek; Paul Glasziou; Pablo Alonso-Coello; David Atkins; Regina Kunz; Victor Montori; Roman Jaeschke; David Rind; Philipp Dahm; Elie A Akl; Joerg Meerpohl; Gunn Vist; Elise Berliner; Susan Norris; Yngve Falck-Ytter; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2012-04-27       Impact factor: 6.437

2.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

3.  Erratum to: Devoe DJ, Peterson A, Addington J. Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-Analysis.

Authors: 
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

4.  The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Authors:  Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

5.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

6.  Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.

Authors:  Patrick D McGorry; Barnaby Nelson; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Annette Thampi; Gregor E Berger; G Paul Amminger; Magenta B Simmons; Daniel Kelly; Grad Dip; Andrew D Thompson; Alison R Yung
Journal:  J Clin Psychiatry       Date:  2012-11-27       Impact factor: 4.384

Review 7.  Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.

Authors:  Konstantinos Mantzoukis; Manuel Rodríguez-Perálvarez; Elena Buzzetti; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

Review 8.  Interventions for hereditary haemochromatosis: an attempted network meta-analysis.

Authors:  Elena Buzzetti; Maria Kalafateli; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-08

9.  Approaches to interpreting and choosing the best treatments in network meta-analyses.

Authors:  L Mbuagbaw; B Rochwerg; R Jaeschke; D Heels-Andsell; W Alhazzani; L Thabane; Gordon H Guyatt
Journal:  Syst Rev       Date:  2017-04-12

10.  Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS.

Authors:  P Fusar-Poli; M Cappucciati; G Rutigliano; T Y Lee; Q Beverly; I Bonoldi; J Lelli; S J Kaar; E Gago; M Rocchetti; R Patel; V Bhavsar; S Tognin; S Badger; M Calem; K Lim; J S Kwon; J Perez; P McGuire
Journal:  Psychiatry J       Date:  2016-05-30
View more
  66 in total

1.  Does the Fast Track Intervention Prevent Later Psychosis Symptoms?

Authors:  Natalie Goulter; Robert J McMahon; Kenneth A Dodge
Journal:  Prev Sci       Date:  2019-11

2.  What you want may not be what you like: A test of the aberrant salience hypothesis in schizophrenia risk.

Authors:  Lilian Yanqing Li; Mayan K Castro; Elizabeth A Martin
Journal:  Cogn Affect Behav Neurosci       Date:  2020-08       Impact factor: 3.282

3.  Early intervention in psychosis in low- and middle-income countries: a WPA initiative.

Authors:  Swaran P Singh; Afzal Javed
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

4.  Development and Validation of a Dynamic Risk Prediction Model to Forecast Psychosis Onset in Patients at Clinical High Risk.

Authors:  Erich Studerus; Katharina Beck; Paolo Fusar-Poli; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

5.  Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis.

Authors:  Amedeo Minichino; Morwenna Senior; Natascia Brondino; Sam H Zhang; Beata R Godwlewska; Philip W J Burnet; Andrea Cipriani; Belinda R Lennox
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

6.  Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Rashmi Patel; Lorenzo Signorini; Syed Miah; Thomas Spencer; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-04-18       Impact factor: 9.306

Review 7.  Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings.

Authors:  Kenji Hashimoto
Journal:  Curr Psychiatry Rep       Date:  2019-07-05       Impact factor: 5.285

8.  The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials.

Authors:  Joseph Firth; Scott B Teasdale; Kelly Allott; Dan Siskind; Wolfgang Marx; Jack Cotter; Nicola Veronese; Felipe Schuch; Lee Smith; Marco Solmi; André F Carvalho; Davy Vancampfort; Michael Berk; Brendon Stubbs; Jerome Sarris
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

9.  Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.

Authors:  Laura A Yoviene Sykes; Maria Ferrara; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Kristen A Woodberry; Albert R Powers; Allison N Ponce; John D Cahill; Jessica M Pollard; Vinod H Srihari; Scott W Woods
Journal:  Schizophr Res       Date:  2019-12-19       Impact factor: 4.939

10.  Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis.

Authors:  Jean Addington; Daniel J Devoe; Olga Santesteban-Echarri
Journal:  Curr Treat Options Psychiatry       Date:  2019-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.